325 related articles for article (PubMed ID: 24354574)
1. The incretin effect does not differ in trained and untrained, young, healthy men.
Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
[TBL] [Abstract][Full Text] [Related]
2. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
3. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
4. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
5. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.
Prévost G; Ducrotté P; Cailleux A; Khalfi K; Basuyau JP; Lefebvre H; Kuhn JM
Neurogastroenterol Motil; 2013 Aug; 25(8):694-9. PubMed ID: 23663508
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
7. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
8. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
9. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
10. Postprandial plasma incretin hormones in exercise-trained versus untrained subjects.
Weiss EP; Royer NK; Fisher JS; Holloszy JO; Fontana L
Med Sci Sports Exerc; 2014 Jun; 46(6):1098-103. PubMed ID: 24576859
[TBL] [Abstract][Full Text] [Related]
11. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
[TBL] [Abstract][Full Text] [Related]
12. Incretin effect after oral amino acid ingestion in humans.
Lindgren O; Pacini G; Tura A; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2015 Mar; 100(3):1172-6. PubMed ID: 25490278
[TBL] [Abstract][Full Text] [Related]
13. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids.
Gojda J; Straková R; Plíhalová A; Tůma P; Potočková J; Polák J; Anděl M
Ann Nutr Metab; 2017; 70(4):293-302. PubMed ID: 28595189
[TBL] [Abstract][Full Text] [Related]
14. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Nauck MA; Siemsglüss J; Orskov C; Holst JJ
Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
[TBL] [Abstract][Full Text] [Related]
15. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
[TBL] [Abstract][Full Text] [Related]
16. The incretin effect in critically ill patients: a case-control study.
Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
[TBL] [Abstract][Full Text] [Related]
17. Incretin levels in polycystic ovary syndrome.
Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
[TBL] [Abstract][Full Text] [Related]
19. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
Oh TJ; Kim MY; Shin JY; Lee JC; Kim S; Park KS; Cho YM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):221-7. PubMed ID: 23405851
[TBL] [Abstract][Full Text] [Related]
20. Incretin and islet hormone responses to meals of increasing size in healthy subjects.
Alsalim W; Omar B; Pacini G; Bizzotto R; Mari A; Ahrén B
J Clin Endocrinol Metab; 2015 Feb; 100(2):561-8. PubMed ID: 25375983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
